Polen Capital's position in GeneDx Holdings is currently worth $4.21M. That's 0.03% of their equity portfolio (67th largest holding). The first GeneDx Holdings trade was made in Q2 2025. Since then Polen Capital bought shares one more times and sold shares on two occasions. The investor's estimated purchase price is $6.22M, resulting in a loss of 32%.